Integrating Risk Management Into Drug Development
ISBSS Seminar Series presents Paul R. Eisenberg, Senior V.P., Global Regulatory Affairs, Amgen. Dr. Eisenberg's talk gives an understanding of how risk assessment and risk management should be integrated into drug development, provides a discussion of approaches to safety signal assessment during drug development, and goes over the basic considerations for risk management in drug development and after approval.
For more information, please contact Kathryn McNevin at kathryn_mcnevin[at symbol]kgi.edu or (909) 607-0120.
|Where:||KGI Main Campus, 517 Bldg. - Lecture Hall|
|When:||October 18, 2013, 12:00 p.m. - 1:00 p.m.|